title: Chronic bleeding secondary to an unresectable duodenal adenocarcinoma controlled with sucralfate and famotidine.
authors.forename: F
authors.initials: F
authors.lastname: Gonzales-Rosales
authors.forename: D
authors.initials: D
authors.lastname: Walsh
authors.forename: L
authors.initials: L
authors.lastname: Burkons
authors.forename: J
authors.initials: J
authors.lastname: Burkons
authors.forename: H R
authors.initials: HR
authors.lastname: Horvitz
mesh_terms: D000230:Adenocarcinoma / Q000150:complications*; D000368:Aged; D004379:Duodenal Neoplasms / Q000150:complications*; D015738:Famotidine / Q000627:therapeutic use*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D013392:Sucralfate / Q000627:therapeutic use*
chemical_list: D005765:Gastrointestinal Agents; D006635:Histamine H2 Antagonists; D013392:Sucralfate; D015738:Famotidine